EN
登录

细胞培养市场规模将增加177.4亿美元,传染病的增加推动了市场增长

Cell culture market size to increase by USD 17.74 billion, The increase in infectious disease drives the market growth, Technavio

CISION 等信源发布 2024-03-07 05:36

可切换为仅中文


NEW YORK, March 6, 2024 /PRNewswire/ -- The Cell Culture Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market size is forecast to grow by USD 17.74 billion between 2022 and 2027 at a CAGR of 11.3%. The market is driven by factors such as the increase in infectious diseases, growing demand for biopharmaceuticals, and high growth potential from emerging regions.

纽约,2024年3月6日/PRNewswire/--Technavio发布了《2023-2027年细胞培养市场(按产品、最终用户和地理位置)-预测和分析报告》。2022年至2027年间,市场规模预计将增长177.4亿美元,复合年增长率为11.3%。该市场受到传染病增加、生物制药需求增长以及新兴地区高增长潜力等因素的驱动。

However, the high cost of equipment is hindering the market growth..

然而,设备的高成本阻碍了市场的增长。。

Continue Reading

继续阅读

Technavio has announced its latest market research report titled Global Cell Culture Market

Technavio发布了最新的市场研究报告,名为《全球细胞培养市场》

The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market.

该报告全面分析了区域层面的增长机会、新产品发布、最新趋势以及全球市场大流行后的复苏。

Download A PDF Sample Report

下载PDF示例报告

Regional AnalysisBy region, the global cell culture market is segmented into North America, Europe, Asia, and Rest of World. North America is estimated to contribute 39% to the growth of the global market over the forecast period. The vendors operating in the region are making significant investments in new manufacturing facilities.

区域分析根据地区,全球细胞培养市场分为北美,欧洲,亚洲和世界其他地区。据估计,在预测期内,北美对全球市场的增长贡献率为39%。在该地区运营的供应商正在对新的制造设施进行重大投资。

This coupled with the rising number of cancer cases is driving the growth of the cell culture market in North America.Buy the reportKey CompanyThe cell culture market report includes information on the key products and recent developments of leading vendors, including:.

再加上癌症病例数量的增加,推动了北美细胞培养市场的增长。购买报告key Company细胞培养市场报告包括主要供应商的关键产品和最新发展的信息,包括:。

Agilent Technologies Inc. - The company offers cell culture products such as Seahorse XF cell culture plates.

安捷伦科技公司-该公司提供细胞培养产品,如Seahorse XF细胞培养板。

Becton Dickinson and Co. - The company offers cell culture products such as BD BACTEC Peds Plus medium and BD BACTEC Lytic Anaerobic medium.

Becton Dickinson and Co.-该公司提供细胞培养产品,如BD BACTEC Peds Plus培养基和BD BACTEC裂解厌氧培养基。

Bio Techne Corp. - The company offers cell culture products such as New ExCellerate iPSC Expansion Medium.

Bio-Techne Corp.-该公司提供细胞培养产品,如新型Excellate iPSC扩增培养基。

CLS Cell Lines Service GmbH - The company offers cell culture products such as 3T3-Swiss albino growing culture.

CLS细胞系服务有限公司-该公司提供细胞培养产品,如3T3瑞士白化病生长培养。

Market Segmentation

市场细分

By product, the market is segmented into consumables and equipment. The consumables segment accounted for the largest share of the market in 2022.

根据产品,市场分为消耗品和设备。2022年,消耗品部门占据了最大的市场份额。

By geography, the market is segmented into North America, Europe, Asia, and Rest of World. North America held the largest share of the market in 2022.

根据地理位置,市场分为北美、欧洲、亚洲和世界其他地区。2022年,北美占据了最大的市场份额。

Analyst ReviewIn the dynamic landscape of biotechnology, the Cell Culture Market stands out as a thriving domain, propelled by relentless innovation and growing demand. The cultivation of cells in a controlled environment outside their natural habitat has become indispensable in various fields, ranging from pharmaceuticals and biotechnology to regenerative medicine and cancer research.The global Cell Culture Market is witnessing exponential growth, driven by factors such as increasing investments in research and development, rising prevalence of chronic diseases, and advancements in tissue engineering techniques.

分析师回顾了生物技术的动态前景,细胞培养市场作为一个蓬勃发展的领域脱颖而出,受到无情的创新和不断增长的需求的推动。从制药和生物技术到再生医学和癌症研究,在自然栖息地之外的受控环境中培养细胞在各个领域都变得不可或缺。在研究和开发投资增加、慢性病患病率上升以及组织工程技术进步等因素的推动下,全球细胞培养市场正在呈指数增长。

Key players in the market are continuously striving to enhance their product offerings, catering to the diverse needs of researchers and biopharmaceutical companies worldwide.One of the primary drivers fueling the expansion of the Cell Culture Market is the escalating demand for biopharmaceuticals. With a growing emphasis on personalized medicine and targeted therapies, pharmaceutical companies are increasingly relying on cell culture techniques to develop novel biologics and vaccines.

市场的主要参与者正在不断努力提高其产品供应,以满足全球研究人员和生物制药公司的不同需求。推动细胞培养市场扩张的主要驱动因素之一是对生物制药的需求不断上升。随着对个性化医疗和靶向治疗的日益重视,制药公司越来越依赖细胞培养技术来开发新型生物制剂和疫苗。

Moreover, the advent of 3D cell culture systems has revolutionized drug discovery and toxicity testing, offering more physiologically relevant models for preclinical studies.Innovations in cell culture technology have paved the way for the development of advanced culture media, serum-free formulations, and automated systems, enabling researchers to achieve higher reproducibility and scalability in their experiments.

此外,3D细胞培养系统的出现彻底改变了药物发现和毒性测试,为临床前研究提供了更多生理相关模型。细胞培养技术的创新为先进培养基,无血清制剂和自动化系统的开发铺平了道路,使研究人员能够在实验中实现更高的可重复性和可扩展性。

Furthermore, the emergence of stem cell culture and organoid technology holds immense promise for regenerative medicine and disease modeling, driving further growth in the market.Geographically, North America dominates the Cell Culture Market, owing to the presence of.

此外,干细胞培养和类器官技术的出现为再生医学和疾病建模带来了巨大的希望,推动了市场的进一步增长。在地理上,由于存在,北美在细胞培养市场上占据主导地位。

The 3D cell culture market size is expected to increase by USD 1.28 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 15.69%. The increase in infectious diseases is notably driving the 3D cell culture market growth, although factors such as high cost of equipment may impede the market growth..

从2021年到2026年,3D细胞培养市场规模预计将增加12.8亿美元,市场增长势头将以15.69%的复合年增长率加速。传染病的增加显着推动了3D细胞培养市场的增长,尽管设备成本高等因素可能会阻碍市场的增长。。

The cell culture media and reagents market size is expected to increase by USD 2.26 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 7.03%. The advancements in the life science industry is notably driving the cell culture media and reagents market growth, although factors such as lack of skilled personnel may impede the market growth..

2020年至2025年,细胞培养基和试剂市场规模预计将增加22.6亿美元,市场增长势头将以7.03%的复合年增长率加速。生命科学行业的进步正在显著推动细胞培养基和试剂市场的增长,尽管缺乏熟练人员等因素可能会阻碍市场的增长。。

Table of contents:1 Executive Summary2 Market Landscape3 Market Sizing4 Historic Market Size5 Five Forces Analysis6 Market Segmentation by Product7 Market Segmentation by End-User8 Customer Landscape9 Geographic Landscape10 Drivers, Challenges, and Trends11 Company Landscape12 Company Analysis13 AppendixAbout USTechnavio is a leading global technology research and advisory company.

目录:1执行摘要2市场景观3市场规模4历史市场规模5五力分析6产品市场细分7最终用户市场细分8客户景观9地理景观10驱动因素、挑战和趋势11公司景观12公司分析13附录关于USTechnavio是一家领先的全球技术研究和咨询公司。

Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries.

他们的研究和分析侧重于新兴市场趋势,并提供可行的见解,以帮助企业识别市场机会并制定有效的战略来优化其市场地位。Technavio的报告库拥有500多名专业分析师,由17000多份报告和统计数据组成,涵盖了50个国家的800多种技术。

Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.ContactTechnavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: media@technavio.comWebsite: www.technavio.com/SOURCE Technavio.

他们的客户群包括各种规模的企业,包括100多家财富500强公司。这一不断增长的客户群依靠Technavio的全面覆盖范围、广泛的研究和可行的市场见解来确定现有和潜在市场的机会,并评估其在不断变化的市场情景中的竞争地位。联系TechNavio Research Jesse MaidaMedia&Marketing ExecutiveUS:+1 844 364 1100UK:+44 203 893 3200电子邮件:media@technavio.comWebsite:www.technavio.com/SOURCE technavio。